The cost for a one-month supply of the drugs lowest dose (2.5 mg) recommended only as a starter dose went from $349 to $299, while the 5 mg dose went from $499 per month to $399
g , Current responses at a holding potential of 70 mV elicited by NMDA bath application in GLP-1 receptor-positive neurons of the arcuate nucleus (ARC) with bath application of 50 M GLP-1MK-801, 50 M GLP-1, 50 M MK-801 or artificial cerebrospinal fluid (aCSF)
One little-reported aspect is SIKis also have potential as a treatment for diseases causing severe sun-sensitivity, like erythropoietic protoporphyria, or anomalies in skin pigmentation, like vitiligo
Polycystic ovary syndrome: Etiology, current management, and future therapeutics
Noom, Found and Calibrate give the market strong digital-care provider depth